Table of Contents

1 Study Coverage

• 1.1 Pharma Grade Glycine Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Pharma Grade Glycine Market Size Growth Rate by Product
  • 1.4.2 Chloroacetic Acid Amide Solution
  • 1.4.3 Biosynthesis
• 1.5 Market by End User
  • 1.5.1 Global Pharma Grade Glycine Market Size Growth Rate by End User
  • 1.5.2 Hospitals
  • 1.5.3 Labs
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Pharma Grade Glycine Market Size
  • 2.1.1 Global Pharma Grade Glycine Revenue 2014-2025
  • 2.1.2 Global Pharma Grade Glycine Sales 2014-2025
• 2.2 Pharma Grade Glycine Growth Rate by Regions
  • 2.2.1 Global Pharma Grade Glycine Sales by Regions
  • 2.2.2 Global Pharma Grade Glycine Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Pharma Grade Glycine Sales by Manufacturers
  • 3.1.1 Pharma Grade Glycine Sales by Manufacturers
  • 3.1.2 Pharma Grade Glycine Sales Market Share by Manufacturers
  • 3.1.3 Global Pharma Grade Glycine Market Concentration Ratio (CR5 and HHI)
• 3.2 Pharma Grade Glycine Revenue by Manufacturers
  • 3.2.1 Pharma Grade Glycine Revenue by Manufacturers (2014-2019)
  • 3.2.2 Pharma Grade Glycine Revenue Share by Manufacturers (2014-2019)
• 3.3 Pharma Grade Glycine Price by Manufacturers
• 3.4 Pharma Grade Glycine Manufacturing Base Distribution, Product Types
  • 3.4.1 Pharma Grade Glycine Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Pharma Grade Glycine Product Type
  • 3.4.3 Date of International Manufacturers Enter into Pharma Grade Glycine Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Pharma Grade Glycine Sales by Product
• 4.2 Global Pharma Grade Glycine Revenue by Product
• 4.3 Pharma Grade Glycine Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Pharma Grade Glycine Breakdown Data by End User

6 North America

• 6.1 North America Pharma Grade Glycine by Countries
  • 6.1.1 North America Pharma Grade Glycine Sales by Countries
  • 6.1.2 North America Pharma Grade Glycine Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Pharma Grade Glycine by Product
• 6.3 North America Pharma Grade Glycine by End User

7 Europe

• 7.1 Europe Pharma Grade Glycine by Countries
  • 7.1.1 Europe Pharma Grade Glycine Sales by Countries
  • 7.1.2 Europe Pharma Grade Glycine Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Pharma Grade Glycine by Product
• 7.3 Europe Pharma Grade Glycine by End User

8 Asia Pacific

• 8.1 Asia Pacific Pharma Grade Glycine by Countries
  • 8.1.1 Asia Pacific Pharma Grade Glycine Sales by Countries
  • 8.1.2 Asia Pacific Pharma Grade Glycine Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Pharma Grade Glycine by Product
• 8.3 Asia Pacific Pharma Grade Glycine by End User

9 Central & South America

• 9.1 Central & South America Pharma Grade Glycine by Countries
  • 9.1.1 Central & South America Pharma Grade Glycine Sales by Countries
  • 9.1.2 Central & South America Pharma Grade Glycine Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Pharma Grade Glycine by Product
• 9.3 Central & South America Pharma Grade Glycine by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Pharma Grade Glycine by Countries
  • 10.1.1 Middle East and Africa Pharma Grade Glycine Sales by Countries
  • 10.1.2 Middle East and Africa Pharma Grade Glycine Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Pharma Grade Glycine by Product
• 10.3 Middle East and Africa Pharma Grade Glycine by End User

11 Company Profiles

• 11.1 Ajinomoto
  • 11.1.1 Ajinomoto Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Ajinomoto Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Ajinomoto Pharma Grade Glycine Products Offered
  • 11.1.5 Ajinomoto Recent Development
• 11.2 GEO Specialty Chemicals
  • 11.2.1 GEO Specialty Chemicals Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 GEO Specialty Chemicals Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 GEO Specialty Chemicals Pharma Grade Glycine Products Offered
  • 11.2.5 GEO Specialty Chemicals Recent Development
• 11.3 Showa Denko KK
  • 11.3.1 Showa Denko KK Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Showa Denko KK Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Showa Denko KK Pharma Grade Glycine Products Offered
  • 11.3.5 Showa Denko KK Recent Development
• 11.4 Chattem Chemicals
  • 11.4.1 Chattem Chemicals Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Chattem Chemicals Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Chattem Chemicals Pharma Grade Glycine Products Offered
  • 11.4.5 Chattem Chemicals Recent Development
• 11.5 Paras Intermediates Private Limited
  • 11.5.1 Paras Intermediates Private Limited Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Paras Intermediates Private Limited Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Paras Intermediates Private Limited Pharma Grade Glycine Products Offered
  • 11.5.5 Paras Intermediates Private Limited Recent Development
• 11.6 Evonik
  • 11.6.1 Evonik Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Evonik Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Evonik Pharma Grade Glycine Products Offered
  • 11.6.5 Evonik Recent Development
• 11.7 Shijiazhuang Donghua Jinlong Chemical
  • 11.7.1 Shijiazhuang Donghua Jinlong Chemical Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Shijiazhuang Donghua Jinlong Chemical Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Shijiazhuang Donghua Jinlong Chemical Pharma Grade Glycine Products Offered
  • 11.7.5 Shijiazhuang Donghua Jinlong Chemical Recent Development
• 11.8 Hebei Donghua Jiheng Chemical
  • 11.8.1 Hebei Donghua Jiheng Chemical Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Hebei Donghua Jiheng Chemical Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Hebei Donghua Jiheng Chemical Pharma Grade Glycine Products Offered
  • 11.8.5 Hebei Donghua Jiheng Chemical Recent Development
• 11.9 Linxi Hongtai
  • 11.9.1 Linxi Hongtai Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Linxi Hongtai Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Linxi Hongtai Pharma Grade Glycine Products Offered
  • 11.9.5 Linxi Hongtai Recent Development
• 11.10 Hubei Xingfa Chemicals Group
  • 11.10.1 Hubei Xingfa Chemicals Group Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Hubei Xingfa Chemicals Group Pharma Grade Glycine Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Hubei Xingfa Chemicals Group Pharma Grade Glycine Products Offered
  • 11.10.5 Hubei Xingfa Chemicals Group Recent Development
• 11.11 Hebei Donghuajian Chemicals
• 11.12 Zhenxing Chemical
• 11.13 Newtrend Group

12 Future Forecast

• 12.1 Pharma Grade Glycine Market Forecast by Regions
  • 12.1.1 Global Pharma Grade Glycine Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Pharma Grade Glycine Revenue Forecast by Regions 2019-2025
• 12.2 Pharma Grade Glycine Market Forecast by Product
  • 12.2.1 Global Pharma Grade Glycine Sales Forecast by Product 2019-2025
  • 12.2.2 Global Pharma Grade Glycine Revenue Forecast by Product 2019-2025
• 12.3 Pharma Grade Glycine Market Forecast by End User
• 12.4 North America Pharma Grade Glycine Forecast
• 12.5 Europe Pharma Grade Glycine Forecast
• 12.6 Asia Pacific Pharma Grade Glycine Forecast
• 12.7 Central & South America Pharma Grade Glycine Forecast
• 12.8 Middle East and Africa Pharma Grade Glycine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Pharma Grade Glycine Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Pharma Grade Glycine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pharma Grade Glycine market based on company, product type, end user and key regions.

This report studies the global market size of Pharma Grade Glycine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pharma Grade Glycine in these regions.
This research report categorizes the global Pharma Grade Glycine market by top players/brands, region, type and end user. This report also studies the global Pharma Grade Glycine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Ajinomoto
GEO Specialty Chemicals
Showa Denko KK
Chattem Chemicals
Paras Intermediates Private Limited
Evonik
Shijiazhuang Donghua Jinlong Chemical
Hebei Donghua Jiheng Chemical
Linxi Hongtai
Hubei Xingfa Chemicals Group
Hebei Donghuajian Chemicals
Zhenxing Chemical
Newtrend Group

Market size by Product
Chloroacetic Acid Amide Solution
Biosynthesis
Market size by End User
Hospitals
Labs

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pharma Grade Glycine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pharma Grade Glycine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pharma Grade Glycine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pharma Grade Glycine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pharma Grade Glycine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pharma Grade Glycine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.